Brief: Astrazeneca Pharma India To Launch Tremelimumab (Imjudo) In Oct
20/09/2024 14:38
Sept 20 (Reuters) - Astrazeneca Pharma India Ltd
ASTR.NS :
* WILL LAUNCH TREMELIMUMAB (IMJUDO) IN OCT
Source text for Eikon: ID:nNSE4bC3JJ
Further company coverage: ASTR.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan